US2011190496A1PendingUtilityA1
FUSED BICYCLIC mTOR INHIBITORS
Est. expiryNov 17, 2025(expired)· nominal 20-yr term from priority
Inventors:Xin ChenHeather R. CoateAndrew Philip CrewHan-Qing DongAyako HondaMark J. MulvihillPaula A. R. TavaresJing WangDouglas S. WernerKristen Michelle MulvihillKam W. SiuBijoy PanickerApoorba BharadwajLee D. ArnoldMeizhong JinBrian VolkQuinghua WengJames David Beard
A61P 43/00A61P 37/00A61P 37/06A61P 37/02A61P 35/00A61P 9/10A61P 29/00A61P 25/00A61P 19/02C07D 487/04C07D 403/14C07D 253/07C07D 401/04A61K 31/5025C07D 401/14C07D 403/04A61K 31/4985C07D 519/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A compound selected from:
or a pharmaceutically acceptable salt thereof.
23 . The compound of claim 22 , which is selected from:
or a pharmaceutically acceptable salt thereof.
24 . The compound of claim 22 , which is selected from:
or a pharmaceutically acceptable salt thereof.
25 . The compound of claim 22 , which is selected from:
or a pharmaceutically acceptable salt thereof.
26 . The compound of claim 22 , which is selected from:
or a pharmaceutically acceptable salt thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.